|
ZNF471 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.69050012771766E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.671920E-02 |
| Normal-vs-Stage2 |
1.724300E-03 |
| Normal-vs-Stage3 |
1.49980028396612E-11 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
1.147420E-01 |
| Stage1-vs-Stage3 |
1.8065899999975E-05 |
| Stage1-vs-Stage4 |
2.68529642966087E-11 |
| Stage2-vs-Stage3 |
1.723600E-01 |
| Stage2-vs-Stage4 |
6.917300E-03 |
| Stage3-vs-Stage4 |
3.884200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.44280143388187E-11 |
| Normal-vs-AfricanAmerican |
5.492400E-01 |
| Normal-vs-Asian |
8.463200E-01 |
| Caucasian-vs-AfricanAmerican |
2.856100E-02 |
| Caucasian-vs-Asian |
9.086000E-02 |
| AfricanAmerican-vs-Asian |
6.715400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.42894593327492E-12 |
| Normal-vs-Female |
4.219500E-03 |
| Male-vs-Female |
3.536900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.417000E-04 |
| Normal-vs-Age(41-60Yrs) |
4.76370000002113E-07 |
| Normal-vs-Age(61-80Yrs) |
1.25270000039812E-07 |
| Normal-vs-Age(81-100Yrs) |
3.943900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.313800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.807600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.517800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.590400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.236000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.804000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.849600E-01 |
| Normal-vs-Grade 2 |
1.912260E-02 |
| Normal-vs-Grade 3 |
5.45810063812269E-11 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
6.281800E-02 |
| Grade 1-vs-Grade 3 |
3.679800E-02 |
| Grade 1-vs-Grade 4 |
3.921300E-03 |
| Grade 2-vs-Grade 3 |
2.180700E-04 |
| Grade 2-vs-Grade 4 |
1.62436730732907E-12 |
| Grade 3-vs-Grade 4 |
6.3422999962981E-08 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.854460E-02 |
| Normal-vs-ccB subtype |
1.5363044170158E-11 |
| ccA subtype-vs-ccB subtype |
2.155600E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.0284999996113E-07 |
| Normal-vs-N1 |
3.22053494983265E-12 |
| N0-vs-N1 |
4.011600E-04 |
|
|
